Concord Biotech Limited is an R&D based vertically integrated Biotechnology Company, having state-of-the-art manufacturing facilities, offering fermentation & semi-synthetic APIs and Finished dosage forms. Concord practices c-GMP and its facilities are been inspected & approved by Global Regulatory Agencies like USFDA, EU-GMP, Japanese PMDA, Local FDA, WHO-GMP, Korean FDA. and separate manufacturing facility for Finished dosage forms inspected and approved by USFDA & WHO-GMP for solid orals & oral liquids. Concord has diversified portfolio of products in the area of Immunosuppressant, Oncology, Anti-bacterial, Anti-fungal, Animal Health, Enzyme, Statins, and others. Concord also offers Contract Research & Manufacturing services of APIs in the area of fermentation & semi-synthetic molecules as well as for Finished dosage forms. On Finished dosage forms, Concord is initially focusing on solid oral dosage & oral liquids of Immunosuppressant.